A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211. (Q33346607)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211. |
scientific article |
Statements
1 reference
A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211. (English)
1 reference
Vardiman JW
1 reference
Larson RA
1 reference
Byrd JC
1 reference
Peterson B
1 reference
Piro L
1 reference
Saven A
1 reference
Schiffer C
1 reference
1 February 2003
1 reference
1 reference
17
1 reference
323-327
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference